|
UPF3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.320200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.198400E-01 |
| Normal-vs-Stage2 |
5.062000E-01 |
| Normal-vs-Stage3 |
3.018200E-01 |
| Normal-vs-Stage4 |
4.502100E-02 |
| Stage1-vs-Stage2 |
5.494200E-01 |
| Stage1-vs-Stage3 |
1.528170E-01 |
| Stage1-vs-Stage4 |
1.725910E-02 |
| Stage2-vs-Stage3 |
1.376970E-01 |
| Stage2-vs-Stage4 |
3.058300E-02 |
| Stage3-vs-Stage4 |
3.132800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.161200E-01 |
| Normal-vs-AfricanAmerican |
2.778000E-02 |
| Normal-vs-Asian |
2.539400E-01 |
| Caucasian-vs-AfricanAmerican |
1.255190E-03 |
| Caucasian-vs-Asian |
2.990100E-02 |
| AfricanAmerican-vs-Asian |
8.486200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.036200E-01 |
| Normal-vs-Female |
3.438600E-01 |
| Male-vs-Female |
6.961300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.883600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.613600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.972600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.033400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.030600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.685200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.937800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.309400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.308200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.036800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.596600E-04 |
| Normal-vs-Grade 2 |
8.103800E-01 |
| Normal-vs-Grade 3 |
5.628800E-01 |
| Normal-vs-Grade 4 |
1.314450E-02 |
| Grade 1-vs-Grade 2 |
3.023800E-03 |
| Grade 1-vs-Grade 3 |
9.576800E-04 |
| Grade 1-vs-Grade 4 |
1.9315299999989E-05 |
| Grade 2-vs-Grade 3 |
3.310600E-01 |
| Grade 2-vs-Grade 4 |
4.061900E-03 |
| Grade 3-vs-Grade 4 |
3.142000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.410600E-01 |
| Normal-vs-ccB subtype |
9.424900E-03 |
| ccA subtype-vs-ccB subtype |
1.82400999999555E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.991800E-01 |
| Normal-vs-N1 |
4.315800E-03 |
| N0-vs-N1 |
1.135930E-02 |
|
|
